SEARCH

SEARCH BY CITATION

References

  • 1
    Cohen I, Rosen DJD, Shapira J et al. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol 1993; 100: 567570.
  • 2
    Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993; 81: 660664.
  • 3
    Cohen I, Rosen DJD, Shapira J et al. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 1994; 52: 185190.
  • 4
    Kedar RP, Bourne TH, Powels TJ et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994; 343: 13181321.
  • 5
    Cohen I, Rosen DJD, Tepper R et al. Ultrasonographic evaluation of the endometrium with correlation to endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 1993; 5: 275280.
  • 6
    Tepper R, Beyth Y, Altaras MM et al. Value of sonohysterography in asymptomatic, postmenopausal tamoxifen-treated patients. Gynecol Oncol 1997; 64: 386391.
  • 7
    Ciato S, Cecchini S, Bonardi R, Grozzini G. Ultrasonographic surveillance of endometrium in breast cancer patients on adjuvant tamoxifen. Lancet 1994; 244: 60.
  • 8
    Bo J, Auslender R, Pascal B, Gutterman E, Abramovici H. Diagnostic pitfalls of ultrasonographic screening in women treated with tamoxifen. J Reprod Med 1994; 39: 674678.
  • 9
    Exacoustos C, Zupi E, Cangi B, Chiartti M, Arduini D, Ramanini C. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound colour flow Doppler, hysteroscopic and histologic study. Ultrasound Obstet Gynecol 1995; 6: 435442.
  • 10
    Uzieli B, Lewin A, Brufman G, Dorrembus D, Mor-Yosef S. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 1993; 26: 101105.
  • 11
    Cohen I, Tepper R, Rosen DJD et al. Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 1994; 55: 138143.
  • 12
    Cohen I, Altaras MM, Shapira J et al. Time-dependent effect of tamoxifen therapy on endometrial pathologies in asymptomatic, postmenopausal breast cancer patients. Int J Gynecol Pathol 1996; 15: 152157.
  • 13
    Hann LE, Geiss CS, Bach AM, Tao Y, Baum HJ, Barakat RR. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR 1997; 168: 657661.
  • 14
    Hulka CA, Hall DA. Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. AJR 1993; 160: 809812.
  • 15
    Anteby E, Yagel S, Zacut D, Palti Z, Hochner-Celnikier D. False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen [letter]. Lancet 1992; 340: 433434.
  • 16
    Perrot N, Goyot B, Antonine M. The effect of tamoxifen on the endometrium. [letter]. Ultrasound Obstet Gynecol 1994; 4: 8386.
  • 17
    Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 1994; 170: 447451.
  • 18
    Anteby E, Yagel S, Hochner-Celnikier D. Unusual ultrasonographic appearance of the uterus in postmenopausal receiving tamoxifen. [letter]. Am J Obstet Gynecol 1995; 172: 717.
  • 19
    Anteby E, Yagel S, Weissman A et al. Sonographic evaluation of the uterus in postmenopausal women receiving tamoxifen: characterisation of mid-uterine abnormalities. Eur J Obstet Gynecol Reprod Biol 1996; 69: 115119.
  • 20
    Cecchini S, Ciatto S, Bonardi R et al. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients with tamoxifen treatment. Gynecol Oncol 1996; 60: 409411.
  • 21
    Schwartz LB, Snyder J, Horan C, Porges RF, Nachtigall LE, Goldstein SR. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen. Ultrasound Obstet Gynecol 1998; 11: 4853.
  • 22
    Marconi D, Exacoustos C, Cangi B et al. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen. J Am Assoc Gynecol Laparosc 1997; 4: 331339.
  • 23
    Timmerman D, Deprest J, Bourne T, Van den Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 1998; 179: 6270.
  • 24
    Bertelli G, Venturini M, Del Mastro L et al. Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients. Breast Cancer Res Treat 1998; 47: 4146.
  • 25
    Love CDB, Muir BB, Scrimgeour JB, Leonard RCF, Dillon P, Dixon JM. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999; 17: 20502054.
  • 26
    Mourits MJE, Van der Zee AGJ, Willemse PHB et al. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Gynecol Oncol 1999; 73: 2126.
  • 27
    Tesoro MR, Borgida AF, MacLaurin NA, Asuncion CM. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen. Obstet Gynecol 1999; 93: 363366.